Day: November 7, 2019

CHARLESTON, S.C., Nov. 07, 2019 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today reported its financial and operating results for the third quarter ended September 30, 2019.All Amounts are in U.S. DollarsHighlights Net loss for the third quarter of 2019 was $0.3 million as compared to net loss of $2.5 million for the same period in 2018. Net loss for the nine-months ended September 30, 2019 was $5.0 million as compared to net income of $9.3 million for the same period in 2018.As of September 30, 2019, we had $10.9 million of unrestricted cash and cash equivalents.On September 20, 2019, the Company entered into a securities purchase agreement with U.S. institutional investors to purchase $5.0 million (before transaction costs of $0.8 million) of its common shares in a registered direct offering and warrants...

ATLANTA, Nov. 07, 2019 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that it will effect a one-for-15 reverse stock split (reverse split) of its common stock that will become effective on November 14, 2019 after the close of trading on The Nasdaq Global Market. On November 15, 2019, Alimera’s common stock will begin trading on a post-reverse split basis on The Nasdaq Global Market under the existing symbol “ALIM.”The reverse split is primarily intended to bring Alimera into compliance with the minimum bid price requirement for maintaining its listing on The Nasdaq Global Market. The new CUSIP number for the common stock following the reverse split will be 016259202.At...

THE COLONY, Texas, Nov. 07, 2019 (GLOBE NEWSWIRE) — Quest Resource Holding Corporation (NASDAQ: QRHC) (“Quest”), a national leader in environmental reuse, recycling, and waste disposal services, announced that it will release financial results for its third quarter ended September 30, 2019, on Thursday, November 14, 2019, after market close.Ray Hatch, President and Chief Executive Officer, and Laurie Latham, Senior Vice President and Chief Financial Officer, will host a conference call that same day at 5:00 pm ET, to review the Company’s financial results and business outlook. Investors interested in participating on the live call can dial 1-800-289-0438 within the U.S. or 1-323-794-2423 from abroad. Investors can also access the call online through a listen-only webcast on the investor relations section of the...

CALGARY, Alberta, Nov. 07, 2019 (GLOBE NEWSWIRE) — Cequence Energy Ltd. (“Cequence” or the “Company”) (TSX: CQE) is pleased to announce its operating and financial results for the three and nine months ended September 30, 2019. The Company’s Management’s Discussion and Analysis (“MD&A”) and Condensed Consolidated Interim Financial Statements are available at cequence-energy.com and on SEDAR at www.sedar.com.HIGHLIGHTSProduction was 5,238 boe/d, 22% of which was comprised of crude oil and liquids in the third quarter 2019 compared to 6,734 boe/d, 27% of which was comprised of crude oil and liquids for the same period in 2018.Completed scheduled turnarounds at two facilities during the three months ended September 30, 2019 reducing third quarter production by approximately 365 boe/d.Shut in approximately...

CALGARY, Alberta, Nov. 07, 2019 (GLOBE NEWSWIRE) — Chinook Energy Inc. (“our”, “we”, or “us”) (TSX: CKE) announces that we have initiated a formal process to identify, examine and consider a range of strategic alternatives available to us with a view to enhancing shareholder value. We are also announcing our operating and financial results for the three months ended September 30, 2019 (“Q319”). Our unaudited condensed consolidated financial statements and management’s discussion and analysis for the three and nine months ended September 30, 2019 are available on our website (www.chinookenergyinc.com) and filed on SEDAR (www.sedar.com).Initiation of Strategic Review ProcessWith the expected strengthening of our operating cash flows, in part resulting from the pending return to 100% capacity of...

CALGARY, Alberta, Nov. 07, 2019 (GLOBE NEWSWIRE) — Maxim Power Corp. (“MAXIM” or the “Corporation”) announced today the release of financial and operating results for the third quarter ended September 30, 2019. The unaudited condensed consolidated interim financial statements, accompanying notes and Management Discussion and Analysis (“MD&A”) will be available on SEDAR and on MAXIM’s website on November 7, 2019. All figures reported herein are Canadian dollars unless otherwise stated.FINANCIAL HIGHLIGHTSOPERATING RESULTSMAXIM’s operations are comprised of the HR Milner generating facility (“Milner”) and MAXIM’s corporate activities. Milner was offline from April 20, 2017 to June 13, 2018 due to unfavourable power market conditions. MAXIM resumed generation of electricity at Milner on...

SALT LAKE CITY, Nov. 07, 2019 (GLOBE NEWSWIRE) — Quest Solution, Inc. (OTCQB: QUES) (“Quest” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, will host a conference call and webcast on Monday, November 11, 2019 at 11:00 a.m. Eastern Time to discuss the Company’s results for the third quarter and nine months ended September 30, 2019.To access the live webcast, go to the Quest Solution website at www.questsolution.com, and click on the Investor Relations tab.To participate in the call by phone, dial (877) 407-9210 approximately five minutes prior to the scheduled start time. International callers please dial (201) 689-8049.A replay of the teleconference will be available until December 11, 2019 and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. ...

CALGARY, Alberta, Nov. 07, 2019 (GLOBE NEWSWIRE) — Voyageur Minerals Ltd. (TSX.V:VM) (the “Company” or “Voyageur”) is pleased to announce that it has retained the services of Frontier Merchant Capital Group (“FronTier”) to provide marketing and financial communications services.  FronTier is an investor relations and marketing group with a home office in Toronto, Canada.  FronTier will assist the company by increasing market awareness for the company using a number of financial market communications initiatives, including facilitating in-person introductions for the company with retail brokers, institutional advisors and life Sciences/ Pharmaceutical focussed industry analysts, in Toronto and other financial capitals, and through media distribution on national television, radio and multiple on-line channels.Under the...

CALGARY, Alberta, Nov. 07, 2019 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) is pleased to report its financial and operating results for the three and nine months ended September 30, 2019.  Dollar amounts are expressed in United States dollars, except as otherwise noted.Charle Gamba, President and CEO of the Corporation, commented: “The third quarter saw an increase in natural gas production of 28% for the three months ended and 18% for the nine months ended, compared to the same periods in 2018, maintaining stable netbacks at the wellhead of $3.86/Mcf, after opex and royalties.  Looking forward to the remainder of 2019, the Corporation anticipates signing during the week of November 18, 2019, a twelve year take or pay gas sales contract for approximately half of the volume...

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome, today announced a grant of inducement awards to its Chief Medical  Officer, Luisa M. Stamm, MD, PhD on November 6, 2019.The Company granted Dr. Stamm non-qualified stock options to purchase 165,000 shares of the Company’s common stock with an exercise price of $16.11 per share, the closing price of Assembly’s common stock as reported by Nasdaq on November 6, 2019. The option grant was made as a material inducement to Dr. Stamm to accept the Company’s offer of employment as its Chief Medical Officer. The stock options have a ten-year term and vest over four years, with one-fourth...